Exon-skipping antisense oligonucleotides for cystic fibrosis therapy is a research paper published in Proceedings of the National Academy of Sciences (2022). On theSindex it has a DataRank of 0.561. It has been cited 41 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βHHS | NIH | National Institute of General Medical Sciences
Grant: R37GM042699
HHS | NIH | National Heart, Lung, and Blood Institute
Grant: F30HL137326-04
HHS | NIH | National Institute of General Medical Sciences
Grant: T32GM008444
NIGMS NIH HHS
Grant: R01 GM042699
NIGMS NIH HHS
Grant: T32 GM007367
NHLBI NIH HHS
Grant: F30 HL137326
NCI NIH HHS
Grant: P30 CA045508
National Institutes of Health
Grant: 5F30HL137326-04
Antisense-oligonucleotide-directed inhibition of nonsense-mediated mRNA decay of CFTR gene
National Institutes of Health
Grant: 2T32GM008444-24
Medical Scientist Training Program
National Institutes of Health
Grant: 5R37GM042699-28
Biochemistry of Pre-mRNA Splicing
National Institutes of Health
Grant: 3P30CA045508-08S1
CSHL CANCER CENTER SUPPORT GRANT
FWCI
4.92
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals